Jun Guo

Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring <i>c-Kit</i> Mutation or Amplification

Jun Guo, Lu Si, Yan Kong et al. · Journal of Clinical Oncology · 2011 · 680 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

STAT3/p53 pathway activation disrupts IFN-β–induced dormancy in tumor-repopulating cells

Yuying Liu, Jiadi Lv, Jinyan Liu et al. · Journal of Clinical Investigation · 2018 · 104 citations · Full text

Life Sciences, Immunology, Oncology +17

Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma

Jun Guo, Jun Zhu, Xinan Sheng et al. · International Journal of Cancer · 2007 · 61 citations

Life Sciences, Immunology, Oncology +17

High G2 and S‐phase expressed 1 expression promotes acral melanoma progression and correlates with poor clinical prognosis

Tianxiao Xu, Meng Ma, Zhihong Chi et al. · Cancer Science · 2018 · 31 citations · Full text

Medicine, Molecular Biology, Oncology +17

EZH2 Inhibitor Enhances the STING Agonist‒Induced Antitumor Immunity in Melanoma

Tianxiao Xu, Jie Dai, Lirui Tang et al. · Journal of Investigative Dermatology · 2021 · 30 citations · Full text

Medicine, Immunology, Oncology +12